ProCE Banner Activity

Emerging Biological Therapies on the Horizon for β-Thalassemia

Slideset Download

Download this slideset for an expert-curated overview of emerging biological therapies for &beta -thalassemia including review of the latest clinical data leading to the recent approval of the erythroid maturation agent luspatercept for transfusion-dependent disease.

Released: December 06, 2019

Expiration: December 04, 2020

Share

Faculty

Maria Domenica Cappellini

Maria Domenica Cappellini, MD

Professor of Internal Medicine
Chief, Internal Medicine Unit
Internal Medicine Department
University of Milan-Fondazione IRCCS Ca Granda Policlinico Hospital
Milan, Italy

Provided by

ProCE Banner

Supporters

Celgene